PT  - JOURNAL ARTICLE
AU  - Berra, Lorenzo
AU  - Medeiros, Kyle J
AU  - Marrazzo, Francesco
AU  - Patel, Sarvagna
AU  - Imber, David
AU  - Rezoagli, Emanuele
AU  - Yu, Binglan
AU  - Sonny, Abraham
AU  - Bittner, Edward A
AU  - Fisher, Daniel
AU  - Chipman, Daniel
AU  - Sharma, Rohit
AU  - Shah, Hardik
AU  - Gray, Brianna E
AU  - Harris, N Stuart
AU  - Ichinose, Fumito
AU  - Mootha, Vamsi K
TI  - Feasibility of Delivering a 5-Day Normobaric Hypoxia Breathing in Healthy Volunteers in a Hospital Setting
AID  - 10.4187/respcare.11928
DP  - 2024 Jul 30
TA  - Respiratory Care
PG  - respcare.11928
4099  - http://rc.rcjournal.com/content/early/2024/07/30/respcare.11928.short
4100  - http://rc.rcjournal.com/content/early/2024/07/30/respcare.11928.full
AB  - BACKGROUND: Beneficial effects of breathing at FIO2 < 0.21 on disease outcomes have been reported in previous preclinical and clinical studies. However, the safety and intra-hospital feasibility of breathing hypoxic gas for 5 d have not been established. In this study, we examined the physiologic effects of breathing a gas mixture with FIO2 as low as 0.11 in 5 healthy volunteers.METHODS: All 5 subjects completed the study, spending 5 consecutive days in a hypoxic tent, where the ambient oxygen level was lowered in a stepwise manner over 5 d, from FIO2 of 0.16 on the first day to FIO2 of 0.11 on the fifth day of the study. All the subjects returned to an environment at room air on the sixth day. The subjects' SpO2, heart rate, and breathing frequency were continuously recorded, along with daily blood sampling, neurologic evaluations, transthoracic echocardiography, and mental status assessments.RESULTS: Breathing hypoxia concentration dependently caused profound physiologic changes, including decreased SpO2 and increased heart rate. At FIO2 of 0.14, the mean SpO2 was 92%; at FIO2 of 0.13, the mean SpO2 was 93%; at FIO2 of 0.12, the mean SpO2 was 88%; at FIO2 of 0.11, the mean SpO2 was 85%; and, finally, at an FIO2 of 0.21, the mean SpO2 was 98%. These changes were accompanied by increased erythropoietin levels and reticulocyte counts in blood. All 5 subjects concluded the study with no adverse events. No subjects exhibited signs of mental status changes or pulmonary hypertension.CONCLUSIONS: Results of the current physiologic study suggests that, within a hospital setting, delivering FIO2 as low as 0.11 is feasible and safe in healthy subjects, and provides the foundation for future studies in which therapeutic effects of hypoxia breathing are tested.